Passumpsic Savings Bank lessened its position in shares of The Allstate Co. (NYSE:ALL – Free Report) by 1.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 19,614 shares of the insurance provider’s stock after selling 368 shares during the quarter. Allstate comprises about 2.4% of Passumpsic Savings Bank’s investment portfolio, making the stock its 12th biggest holding. Passumpsic Savings Bank’s holdings in Allstate were worth $3,781,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also added to or reduced their stakes in the company. State Street Corp boosted its holdings in shares of Allstate by 1.1% in the 3rd quarter. State Street Corp now owns 11,496,306 shares of the insurance provider’s stock worth $2,190,758,000 after purchasing an additional 126,922 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Allstate by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,228,581 shares of the insurance provider’s stock worth $1,178,164,000 after purchasing an additional 74,537 shares during the period. Strategic Financial Concepts LLC boosted its holdings in shares of Allstate by 15,062.3% in the 4th quarter. Strategic Financial Concepts LLC now owns 1,119,129 shares of the insurance provider’s stock worth $215,757,000 after purchasing an additional 1,111,748 shares during the period. Pathway Financial Advisers LLC boosted its holdings in shares of Allstate by 18,472.5% in the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after purchasing an additional 1,047,019 shares during the period. Finally, FMR LLC boosted its holdings in shares of Allstate by 11.8% in the 3rd quarter. FMR LLC now owns 933,352 shares of the insurance provider’s stock worth $177,010,000 after purchasing an additional 98,179 shares during the period. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on the company. Jefferies Financial Group raised their price target on Allstate from $231.00 to $267.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Barclays decreased their price target on Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a research note on Monday, January 6th. UBS Group raised their price target on Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. The Goldman Sachs Group raised their price target on Allstate from $209.00 to $230.00 and gave the stock a “buy” rating in a research note on Friday, November 15th. Finally, Keefe, Bruyette & Woods raised their price target on Allstate from $235.00 to $240.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 11th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $217.94.
Allstate Trading Down 1.9 %
Shares of NYSE ALL opened at $185.51 on Friday. The firm has a market cap of $49.12 billion, a PE ratio of 10.92, a price-to-earnings-growth ratio of 1.05 and a beta of 0.52. The company has a quick ratio of 0.40, a current ratio of 0.36 and a debt-to-equity ratio of 0.42. The Allstate Co. has a twelve month low of $153.87 and a twelve month high of $209.88. The business has a fifty day simple moving average of $190.25 and a two-hundred day simple moving average of $190.15.
Allstate (NYSE:ALL – Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, topping the consensus estimate of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. Analysts expect that The Allstate Co. will post 18.65 earnings per share for the current fiscal year.
Insider Transactions at Allstate
In other news, CFO Jesse E. Merten sold 40,102 shares of the business’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the transaction, the chief financial officer now directly owns 18,115 shares of the company’s stock, valued at approximately $3,378,990.95. The trade was a 68.88 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.80% of the company’s stock.
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Stock Splits, Do They Really Impact Investors?
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- How to Plot Fibonacci Price Inflection Levels
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.